ReviewClinical journal of oncology nursing2019

Moxetumomab Pasudotox: Clinical Experience in Relapsed/Refractory Hairy Cell Leukemia.

Julie Feurtado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.